Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Chronic rhinosinusitis with nasal polyps (CRSwNP) is a persistent sinonasal mucosa inflammatory disease. MicroRNAs (miRNAs) that are involved in the pathogenesis of CRSwNP in Northern China remain unknown.

Methods: A miRCURY™ LNA Array was used to analyze miRNA profiles in nasal mucosa tissues of CRSwNP patients (n = 19) and healthy controls (n = 10). Subsequent pathways were predicted by DIANA-mirPath software.

Results: Five upregulated miRNAs, including miR-210-5p, miR-3178, miR-585-3p, miR-3146, and miR-320e, and 19 downregulated miRNAs, including miR-32-3p, miR-1299, miR-3196, miR-3924, and miR-548e-3p, were differentially expressed (p < 0.05, fold change >2) in tissues of CRSwNP vs controls. Utilizing the Kyoto Encyclopedia of Genes and Genomes database (KEGG), which is an online database for pathway mapping, mucin type O-glycan biosynthesis pathway was significantly enriched in upregulated miRNAs. Transforming growth factor-beta (TGF-β), transient receptor potential (TRP) channels, and the mitogen-activated protein kinase (MAPK) signaling pathway were significantly linked to downregulated miRNAs.

Conclusion: The mucin type O-glycan biosynthesis pathway and TGF-β signaling pathway are regulated by miRNAs, which could be our focus in the future studies.

Download full-text PDF

Source
http://dx.doi.org/10.1002/alr.22230DOI Listing

Publication Analysis

Top Keywords

mucin type
12
type o-glycan
12
o-glycan biosynthesis
12
transforming growth
8
nasal mucosa
8
chronic rhinosinusitis
8
rhinosinusitis nasal
8
nasal polyps
8
northern china
8
tissues crswnp
8

Similar Publications

Hepatic mucinous cystic neoplasm in a male patient: A case report.

Exp Ther Med

October 2025

Department of Gastroenterology, Xixi Hospital, Hangzhou, Zhejiang 310023, P.R. China.

Hepatic mucinous cystic neoplasms (MCN) are rare cystic tumors that are predominantly observed in females, with a low incidence rate in males. To date, few cases of aggressive MCN have been reported in male patients. The current study reports the case of a 74-year-old male patient who presented to Xixi Hospital with abdominal distension.

View Article and Find Full Text PDF

Background: Morphological features of tumors can reflect the biological behavior of breast carcinoma; however, a consensus macroscopic classification remains elusive. In this study, we aimed to elucidate the relationship between macroscopic morphology and biological behavior of breast carcinoma.

Methods: We evaluated 328 post-operative breast carcinomas, stratifying them by hormone receptor/human epidermal growth factor receptor 2 (HER2) status (luminal-like, luminal-HER2, HER2-positive [non-luminal], triple-negative), and morphological patterns.

View Article and Find Full Text PDF

Mucinous adenocarcinoma (MC) is a very rare type of prostate cancer, accounting for less than 1% of prostate adenocarcinomas, and its etiology is still unclear. Its clinical symptoms are similar to those of prostate hyperplasia and follicular carcinoma of the prostate, which are often misdiagnosed, and a definite diagnosis depends on pathological diagnosis, and the secretion of a large amount of mucus is its pathological characteristic. Surgery and endocrine therapy are the main treatment modalities, followed by radiation therapy and comprehensive therapy.

View Article and Find Full Text PDF

Take it or leave it? Incidental appendectomy at time of gynecologic oncology laparotomy.

Gynecol Oncol Rep

October 2025

Loma Linda University Medical Center, Division of Gynecologic Oncology, Department of Gynecology and Obstetrics, 11175 Campus Street, Coleman Pavilion, Room #11105, Loma Linda, CA 92354, United States.

Objective: The role of appendectomy in gynecologic oncology surgery has primarily been studied in mucinous ovarian pathologies. We sought to assess the safety and potential benefits of performing incidental appendectomy at time of exploratory laparotomy performed by gynecologic oncologists.

Methods: Retrospective chart review of patients undergoing exploratory laparotomy with the gynecologic oncology division.

View Article and Find Full Text PDF

Galectin-9-An Emerging Glyco-Immune Checkpoint Target for Cancer Therapy.

Int J Mol Sci

August 2025

Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

Galectin-9 (Gal-9, ) is a member of the family of carbohydrate-binding lectins known as galectins. Galectins bind a diverse repertoire of galactose-bearing glycoprotein receptors expressed across multiple cell types. These interactions elicit a broad spectrum of pleiotropic effects important in both normal physiology and disease pathogenesis.

View Article and Find Full Text PDF